The t(9;22) chromosome translocation originating the BCR-ABL1 fusion oncoprotein is detected in more than 95% of patients with CML representing the hallmark of the disease [1]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.